Your browser doesn't support javascript.
loading
RosettaSX: Reliable gene expression signature scoring of cancer models and patients.
Kreis, Julian; Nedic, Boro; Mazur, Johanna; Urban, Miriam; Schelhorn, Sven-Eric; Grombacher, Thomas; Geist, Felix; Brors, Benedikt; Zühlsdorf, Michael; Staub, Eike.
Afiliación
  • Kreis J; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany; Faculty of Bioscience, University of Heidelberg, Heidelberg, Germany.
  • Nedic B; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany.
  • Mazur J; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany.
  • Urban M; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany.
  • Schelhorn SE; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany.
  • Grombacher T; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany.
  • Geist F; Therapeutic Innovation Platform Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany.
  • Brors B; Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Core Center, Heidelberg, Germany.
  • Zühlsdorf M; Therapeutic Innovation Platform Oncology & Immuno-Oncology, Merck KGaA, Darmstadt, Germany.
  • Staub E; Department of Translational Medicine, Oncology Bioinformatics, Merck KGaA, Darmstadt, Germany. Electronic address: eike.staub@merckgroup.com.
Neoplasia ; 23(11): 1069-1077, 2021 11.
Article en En | MEDLINE | ID: mdl-34583245
ABSTRACT
Gene expression signatures have proven their potential to characterize important cancer phenomena like oncogenic signaling pathway activities, cellular origins of tumors, or immune cell infiltration into tumor tissues. Large collections of expression signatures provide the basis for their application to data sets, but the applicability of each signature in a new experimental context must be reassessed. We apply a methodology that utilizes the previously developed concept of coherent expression of genes in signatures to identify translatable signatures before scoring their activity in single tumors. We present a web interface (www.rosettasx.com) that applies our methodology to expression data from the Cancer Cell Line Encyclopaedia and The Cancer Genome Atlas. Configurable heat maps visualize per-cancer signature scores for 293 hand-curated literature-derived gene sets representing a wide range of cancer-relevant transcriptional modules and phenomena. The platform allows users to complement heatmaps of signature scores with molecular information on SNVs, CNVs, gene expression, gene dependency, and protein abundance or to analyze own signatures. Clustered heatmaps and further plots to drill-down results support users in studying oncological processes in cancer subtypes, thereby providing a rich resource to explore how mechanisms of cancer interact with each other as demonstrated by exemplary analyses of 2 cancer types.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Programas Informáticos / Neoplasias de la Mama / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Linfoma de Células B Grandes Difuso / Biología Computacional / Transcriptoma Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Programas Informáticos / Neoplasias de la Mama / Biomarcadores de Tumor / Regulación Neoplásica de la Expresión Génica / Linfoma de Células B Grandes Difuso / Biología Computacional / Transcriptoma Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Neoplasia Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Alemania
...